The YP-P10 pre-clinical head-to-head study, jointly conducted by five people including Dr. Kyungho Park of Naason Science
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
The OPTASE range is a safe, tested and expert recommended 3-step regime to help tackle the cause and symptoms of eye conditions
Cyclosporine Ophthalmic Nanoemulsion is a preservative-free Nanoemulsion that has been approved in South Korea, Peru and several countries in the Middle East for treatment of dry eye syndrome
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
First of its kind screening for Glaucoma at grass root level over 10k screened already
Subscribe To Our Newsletter & Stay Updated
